MTOR and pneumonitis: The syndrome of “rapamycin lung” is a diffuse pneumonitis observed with mTOR (mammalian target of rapamycin) inhibitors (e.g., everolimus, sirolimus and temsirolimus), generally in concert with other infections, including community-acquired respiratory viruses and Pneumocystis.